Tevogen Bio Holdings Inc.
TVGN
$0.39
-$0.02-4.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.62M | 2.74M | 7.16M | 7.42M | 2.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.73M | 5.44M | 10.36M | 9.36M | 6.09M |
| Operating Income | -5.73M | -5.44M | -10.36M | -9.36M | -6.09M |
| Income Before Tax | -5.73M | -5.50M | -10.37M | -9.44M | -5.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.73M | -5.50M | -10.37M | -9.44M | -5.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.73M | -5.50M | -10.37M | -9.44M | -5.88M |
| EBIT | -5.73M | -5.44M | -10.36M | -9.36M | -6.09M |
| EBITDA | -5.73M | -5.35M | -10.32M | -9.32M | -6.05M |
| EPS Basic | -0.03 | -0.03 | -0.07 | -0.09 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.04 | -0.06 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.07 | -0.09 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.04 | -0.06 | -0.02 |
| Average Basic Shares Outstanding | 196.03M | 184.31M | 161.41M | 106.69M | 170.17M |
| Average Diluted Shares Outstanding | 196.03M | 184.31M | 161.41M | 106.69M | 170.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |